Related Experiment Video

Updated: Jul 15, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

An unusual case of cardiac amyloidosis

Brian Garibaldi1, David Zaas

  • 1Department of Medicine, The Johns Hopkins Hospital, 601 North Caroline Street, Baltimore, Maryland 21287, USA. bgariba1@jhmi.edu

Journal of General Internal Medicine
|April 21, 2007
PubMed

Insights

Identifying the cause of cardiac amyloidosis is crucial for effective treatment. This case highlights diagnostic challenges and the need for a clear algorithm to determine amyloidosis etiology before therapy.

Area of Science:

  • Cardiology
  • Hematology
  • Pathology

Background:

  • Cardiac amyloidosis, a restrictive cardiomyopathy, stems from systemic amyloidoses.
  • Treatment for cardiac amyloidosis depends on the specific cause of amyloid deposition.
  • Accurate diagnosis of amyloidosis etiology is critical before initiating definitive therapy.

Observation:

  • A patient presumed to have immunoglobulin light chain (AL) amyloidosis presented with a lambda monoclonal protein.
  • Bone marrow biopsy revealed kappa predominant plasma cells, creating a diagnostic dilemma.
  • This discrepancy challenged the initial AL amyloidosis diagnosis.

Findings:

  • The case underscores the complexity in diagnosing the specific type of cardiac amyloidosis.
  • Discrepant findings between serum protein electrophoresis and bone marrow biopsy can occur.
  • Accurate etiological diagnosis is essential for appropriate patient management.

Implications:

  • A diagnostic algorithm is proposed to aid in identifying the cause of cardiac amyloidosis.
  • This approach aims to improve the accuracy of diagnosis and guide treatment decisions.
  • Understanding the diverse etiologies of cardiac amyloidosis is key for better patient outcomes.

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...